J Clin Oncol 1997, 15: 2403–2413 PubMed 2 Spratlin J, Sangha R,

J Clin Oncol 1997, 15: 2403–2413.PubMed 2. Spratlin J, Sangha R, Glubrecht

D, Dabbagh L, Young JD, Dumontet C, Cass C, Lai R, Mackey JR: The absence of human equilibrative nucleoside Captisol price transporter 1 is associated with reduced survival in selleck products patients with gemcitabine-treated pancreas adenocarcinoma. Clin Cancer Res 2004, 10: 6956–6961.CrossRefPubMed 3. Giovannetti E, Del Tacca M, Mey V, Funel N, Nannizzi S, Ricci S, Orlandini C, Boggi U, Campani D, Del Chiaro M, Iannopollo M, Bevilacqua G, Mosca F, Danesi R: Transcription analysis of human equilibrative nucleoside transpoter-1 predicts survival in pancreas cancer patients treated with gemcitabine. Cancer Res 2006, 66: 3928–3935.CrossRefPubMed 4. Mackey JR, Yao SY, Smith KM, Karpinski E, Baldwin SA, Cass CE, Young JD: Gemcitabine transport in xenopus oocytes expressing recombinant plasma membrane mammalian nucleoside transporters. J Natl Cancer Inst 1999, 91: 1876–1881.CrossRefPubMed 5. Kroep JR, Loves WJP, Wilt CL, Alvarez E, Talianidis

I, Boven E, Braakhuis BJ, van Groeningen CJ, Pinedo HM, Peters GJ: Pretreatment deoxycytidine kinase levels predict in vivo gemcitabine sensitivity. Mol Cancer Ther 2002, 1: 371–376.PubMed 6. Sebastiani V, Ricci F, Rubio-Viquiera B, Kulesza P, Yeo CJ, Hidalgo M, Klein A, Laheru D, Iacobuzio-Donahue CA: Immunohistochemical and genetic evaluation of deoxycytidine kinase in pancreatic cancer: relationship to molecular mechanisms of gemcitabine resistance and survival. Clin Cancer Res 2006, 12: 2492–2497.CrossRefPubMed JPH203 7. Tada M, Komatsu Y, Kawabe T, Sasahira N, Isayama H, Toda N, Shiratori Y, Omata M: Quantitative Metalloexopeptidase analysis of K-ras gene mutation in pancreatic tissue obtained by endoscopic ultrasonography-guided fine needle aspiration: clinical utility for diagnosis of pancreatic tumor. Am J Gastroenterol 2002, 97: 2263–2270.CrossRefPubMed 8. Khalid A, Nodit L, Zahid M, Bauer K, Brody D, Finkelstein SD, McGrath KM: Endoscopic ultrasound

fine needle aspiration DNA analysis to differentiate malignant and benign pancreatic masses. Am J Gastroenterol 2006, 101: 2493–2500.PubMed 9. Wiersema MJ, Kochman ML, Cramer HM, Tao LC, Wiersema LM: Endosonograpy-guided real-time fine-needle aspiration biopsy. Gastrointest Endosc 1994, 40: 700–707.PubMed 10. Zhu B, Xu F, Bana Y: An evaluation of linear RNA amplification in cDNA microarray gene expression analysis. Mol Genet Metab 2006, 87: 71–79.CrossRefPubMed 11. Takahashi K, Yamao K, Okubo K, Sawaki A, Mizuno N, Ashida R, Koshikawa T, Ueyama Y, Kasugai K, Hase S, Kakumu S: Differential diagnosis of pancreatic cancer and focal pancreatitis by using EUS-guided FNA. Gastrointest Endosc 2005, 61: 76–79.CrossRefPubMed 12.

Comments are closed.